Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health
April 30 2024 - 8:00AM
Business Wire
Carlin Consumer Health (“Carlin”), a preeminent consumer health
business that specializes in acquiring leading over-the-counter
(“OTC”) brands, today announced that it has acquired PENETREX®
(“Penetrex”) from Wellbeam Consumer Health (“Wellbeam”). The
financial terms of the transaction were not disclosed.
Penetrex is a leading joint and muscle care brand trusted by
millions of consumers. As part of the transaction, Penetrex will
now become a brand within the Carlin Consumer Health portfolio.
“We are very excited to add Penetrex to our portfolio of leading
OTC brands,” said Wael Fayad, Chairman of Carlin Consumer Health
and a Partner at Hildred Capital. “We believe that Penetrex will be
an important driver of Carlin’s growth in the years to come and is
highly complementary to the world-class consumer health brands that
are in our portfolio.”
“Penetrex is an ideal fit for Carlin’s portfolio and their
team’s experience and expertise in the consumer health market will
be instrumental in helping to further grow and expand the brand,”
said Chris Marschall, CEO of Wellbeam Consumer Health. “We wish the
Carlin team success as they work to seamlessly integrate Penetrex
into their growing portfolio.”
Founded in 2022, Carlin Consumer Health is sponsored by Hildred
Capital, Bourne Partners Strategic Capital, and The Emerson
Group—and markets leading consumer health brands.
Sidley Austin LLP served as legal adviser to Carlin. Lincoln
International acted as exclusive financial adviser and Jones Day as
legal adviser to Wellbeam.
About Carlin Consumer Health
Founded in 2022 and based in New York, NY, Carlin is a consumer
health business uniquely positioned to acquire leading
over-the-counter brands. Carlin was formed by leading sponsors,
Hildred Capital, Bourne Partners Strategic Capital, and The Emerson
Group. For more information, please visit
carlinconsumerhealth.com.
About Wellbeam Consumer Health
Wellbeam Consumer Health is a diversified portfolio of
differentiated wellness brands, including TruSkin, Eu Natural, and
BioTRUST. Wellbeam is accelerating its brands by expanding on its
eCommerce strength and leadership, building out a growing
omni-channel retail presence, and launching meaningful new product
innovation. Wellbeam brands aim to make a difference by enabling
people to reach their wellness goals and live healthier lives.
Wellbeam is backed by American Pacific Group. For more information,
please visit wellbeam.com.
About Hildred Capital
Hildred Capital is a healthcare-focused private equity firm that
specializes in operationally-intensive, control-oriented
investments in lower middle-market companies. Hildred partners with
innovative and growth-oriented management teams to build
high-quality businesses. The Hildred team possesses extensive
experience across the healthcare industry, and seeks to leverage
its unique blend of strategic, financial, commercial and
operational acumen to drive strategic growth and create value for
its portfolio companies and investment partners. Hildred currently
has more than $1.5 billion in assets under management. For more
information, please visit www.hildred.com and follow the firm on
LinkedIn.
About Bourne Partners Strategic Capital
Headquartered in Charlotte, N.C., Bourne Partners Strategic
Capital (“BPSC”) is a private equity and growth equity investment
firm focused exclusively on the pharmaceutical, pharma services and
consumer healthcare sectors (10 current portfolio companies). As
owners and operators with over 20 years of experience, BPSC has
investment, strategic and operational experience in companies
ranging from $5M to $3B in equity value and seeks to align and
partner with management teams and other owners in these sectors to
grow their business. BPSC is a related company of Bourne Partners,
which offers investment banking and advisory services in the same
key focus areas. For more information, please visit Bourne Partners
Strategic Capital at
https://www.bourne-partners.com/strategic-capital/
About The Emerson Group
The Emerson Group is a consumer products equity organization
singularly focused on brands reaching maximum potential that
connect over-the-counter health and beauty brands to loyal
shoppers. The Emerson Group specializes in strategic planning,
category assessments, due diligence, acquisition, and feasibility
studies. The Emerson Group also provides the efficient logistics
infrastructure necessary to build brands and offers data and
shopper insights for making connections between brands and their
target consumers. The Emerson Group leads the industry as a retail
partner of choice and provides advanced analytical tools and
research for proprietary insights.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240430378244/en/
Media Contact for Hildred Capital: Mike Geller Prosek
Partners mgeller@prosek.com